Reactions to BIT are dose related. Look into the various doses and delivery methods of all the BIT trials and you'll see that the current dose strategy is just dandy. I'm confident of that one.
- Forums
- ASX - By Stock
- BIT
- Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial
Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-75
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.8¢ | $3.69K | 197.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 480522 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 0.017 |
11 | 2337904 | 0.016 |
16 | 2996688 | 0.015 |
7 | 5758433 | 0.014 |
5 | 1849000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 480522 | 6 |
0.020 | 1094211 | 7 |
0.021 | 600000 | 1 |
0.022 | 340866 | 2 |
0.023 | 508000 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online